TRIM27 Antikörper (full length)
Kurzübersicht für TRIM27 Antikörper (full length) (ABIN7879207)
Target
Alle TRIM27 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Bindungsspezifität
- full length
-
Verwendungszweck
- TRIM27 Antibody (azide and preservative free)
-
Aufreinigung
- Protein A/G affinity
-
Immunogen
- Recombinant full-length human TRIM27 protein was used as the immunogen for the TRIM27 antibody.
-
Isotyp
- IgG2a
-
-
-
-
Applikationshinweise
- Optimal dilution of the TRIM27 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the TRIM27 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- TRIM27 (Tripartite Motif Containing 27 (TRIM27))
-
Andere Bezeichnung
- TRIM27
-
Hintergrund
- Defects in TRIM27 are a cause of thyroid papillary carcinoma (TPC). TPC is a common tumor of the thyroid that typically arises as an irregular, solid or cystic mass from otherwise normal thyroid tissue. Papillary carcinomas are malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells.
-
UniProt
- P14373
Target
-